Curcumin is extracted from the turmeric root and is known to have anti-inflammatory as well as antioxidant properties.
Though turmeric has been used over the ages the active ingredient curcumin which is just 5% of the composition has been isolated and used in medical formulations in the last 15-20 years. Most of the clinical data available is based on studies using non conjugated or glucuronidated free form of the ingredient. Curcumin however is known to be rapidly broken down conjugated and excreted when taken orally. This changes the form of curcumin into a compound which is not very effective.
Longvida was developed by UCLA Neurologists using a patented SLCP Technology delivers Originally developed to increase systemic bioavailability as well as increase permeability through the blood brain barrier, Longvida today is used in many applications besides brain health.
Patented Solid Lipid Curcumin Particle (SLCPTM) Technology enables the uptake of Free Curcumin through the lymphatic system which is a parallel system to the circulatory system mostly functioning to transport metabolites from cells. Longvida enters the Lymphatic system and since lymph flows very slowly compared to blood it can stay longer in circulation. This ensures 5 times higher bioavailability of Free Curcumin in plasma and ten-fold higher in lymph, when compared to the standard curcumin,
Over 30 published studies which support a number of health applications, including, Cognitive Health, Retinal Health, Vascular Health, Exercise Recovery, Sports Nutrition, Joint Health, Healthy Ageing and Immune Health.
For an ingredient to be safe to use over extended periods of time it should be tested extensively for safety and efficacy. Longvida exceeds testing requirements in key markets like the USA, Europe, Japan and Australia which are known to have very stringent requirements on testing. Among other certifications Longvida has a wealth of Long-term toxicology data published, Non-GMO compliant / verified; Meets or exceeds USP/ICH/Prop-65 standards and is patent protected through US and EP patents with additional patents pending.
Being a global brand manufactured in a US FDA registered facility we ensure world class consistent quality at affordable prices.
Warnings and Contraindications
Curcuminoids may enhance the action of Warfarin, anti-platelet and steroidal anti- inflammatory drugs
Not to be taken by known patients of bile duct obstruction and pregnancy.
Clinically Supported Dosage
Pending Indications: 400-2000mg/day • NOAEL Determined at 720mg/kg
For optimal absorption administer on an empty stomach or with a light meal.
Store at room temperature away from sunlight and moisture.